Dave Hunter highlight a variety of cool life science collaborations he has worked on, including the network models used to describe AIDS transmissions and mixture modelling to describe pediatric cognitive tests. We then talk about the upcoming SDSS 2020 conference, and its newest additions to benefit early career researchers.

There are many places in which ML/AI methods can be of benefit to pharmaceutical research (several have already been covered on the show). David and Demissie explain where AI can fit in to in vivo studies, which carries it’s own benefits, but also with heightened risk to to human test subjects. They go on to cover several other areas of interest including AI for observation studies and real world evidence. It’s a “big tent” conversation as we lead up to the Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development.

Mihaela van der Schaar will be following up in a subsequent episode on this subject.

Dana al Sulaimen’s (MIT) work runs the gamut of biomedical engineering areas. She gives a great presentation on the clinical motivation for her work, engineering sensing platforms, and data analysis. Definitely watch the video for this one for some excellent visual material.

The episode of milk and honey.

Shane shows us some of the real-time data analytics platforms that track the health of dairy cows and honey bees.

Rob Scott, Chief Medical Officer at AbbVie, discusses the importance of a clinician’s perspective for keeping clinical trial development focussed on the patients. Rob talks about how the role of a Chief Medical Officer changes between a large pharma company and small biotechs. He then covers the key areas in which new developments in healthcare technology can help us better understand a patient’s response to therapies and interventions.

Gajanan Bhat and Xinping Cui discuss the major themes of data science in clinical drug and device development.

Eric Stephens, Chief Analytics Officer at Nashville General Hospital, talks about building analytics capacities in the hospital setting and how hospitals select their priorities for new analytics projects. Then he discusses the cool events coming up at CSP 2020 and how applied data scientists have more options than ever for career advancement.

Neurosurgeon and entrepreneur Nick de Pennington talks about the importance of automating clinical tasks to help doctors focus on the most challenging cases.

Niven Narain, CEO of Berg Health, discusses creating value through data platforms and AI in the pharmaceutical industry.